Complex regulation of prothymosin alpha in mammary tumors arising in transgenic mice

[1]  K. Kinzler,et al.  A model for p53-induced apoptosis , 1997, Nature.

[2]  G. Cooper,et al.  Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1 , 1997, Molecular and cellular biology.

[3]  G. Covelo,et al.  Prothymosin alpha binds histones in vitro and shows activity in nucleosome assembly assay. , 1996, Biochimica et biophysica acta.

[4]  M. Schwab,et al.  Conditional expression of N-myc in human neuroblastoma cells increases expression of alpha-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. , 1996, Oncogene.

[5]  K. Mimori,et al.  Expression of prothymosin-alpha and c-myc mRNA in human gastric cancer. , 1996, International journal of oncology.

[6]  K. Vareli,et al.  Regulation of Prothymosin α During the Cell Cycle , 1996 .

[7]  Y. Wang,et al.  Regulation of the cell cycle machinery by oncogenic ras. , 1996, Oncogene.

[8]  C. Dang,et al.  Do products of the myc proto-oncogene play a role in transcriptional regulation of the prothymosin alpha gene? , 1995, Molecular and cellular biology.

[9]  P. Leder,et al.  neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. , 1994, Oncogene.

[10]  S Gaubatz,et al.  An E-box element localized in the first intron mediates regulation of the prothymosin alpha gene by c-myc , 1994, Molecular and cellular biology.

[11]  K. Alitalo,et al.  Repression of cyclin D1: a novel function of MYC. , 1994, Molecular and cellular biology.

[12]  O. Tsolas,et al.  Prothymosin α binds to histone H1 in vitro , 1994 .

[13]  J. Forteza,et al.  Distribution of prothymosin alpha in rat and human adrenal cortex , 1994, The Anatomical record.

[14]  W. Voelter,et al.  Radioimmunoassays for the C-terminus of prothymosin α and the N-terminus of parathymosin α for the measurement of the levels of α-thymosins in human cancer , 1994 .

[15]  J. Zalvide,et al.  Prothymosin alpha mRNA levels are invariant throughout the cell cycle. , 1992, The Journal of biological chemistry.

[16]  D. Werner,et al.  Nucleotide sequence of the murine prothymosin alpha cDNA and its deduced primary and secondary protein structure. , 1991, Biochimica et biophysica acta.

[17]  S. L. Berger,et al.  Nuclear targeting of prothymosin alpha. , 1991, The Journal of biological chemistry.

[18]  J. Bishop,et al.  The MYC protein activates transcription of the alpha‐prothymosin gene. , 1991, The EMBO journal.

[19]  P. Jolicoeur,et al.  Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene , 1989, Cell.

[20]  X. Bustelo,et al.  The expression of prothymosin alpha gene in T lymphocytes and leukemic lymphoid cells is tied to lymphocyte proliferation. , 1989, The Journal of biological chemistry.

[21]  P. Cary,et al.  Prothymosin α is a nuclear protein , 1989 .

[22]  D. Smith,et al.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. , 1988, Gene.

[23]  P. Leder,et al.  Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo , 1987, Cell.

[24]  P. Leder,et al.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes , 1984, Cell.

[25]  R. Cardiff,et al.  Transgenic mouse models of mammary tumorigenesis. , 1993, Cancer surveys.

[26]  M. Mori,et al.  Prothymosin-α mRNA expression correlates with that of c-myc in human colon cancer , 1993 .